#10
Novo Nordisk (NVO)
The Danish pharmaceutical company behind Ozempic and Wegovy rode the GLP-1 weight-loss drug wave to become Europe's most valuable company with returns exceeding 700%, outpacing #1 Costco's growth by over 500% in the same timeframe. This rapid rise delivered 28% average annual returns, nearly double the typical pharma sector benchmark of 15%.
0
Photos (1)
Comments on "Novo Nordisk (NVO)"
Have a take on this ranking?
Comments are how the argument actually happens here. Posting one needs a free account — it takes about a minute.
No comments yet.
The first comment sets the terms of the argument.